|
EP0988301B1
(en)
|
1997-06-12 |
2006-08-09 |
Aventis Pharma Limited |
Imidazolyl-cyclic acetals
|
|
JP6806562B2
(ja)
|
2013-03-15 |
2021-01-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ｅＩＦ２α経路の調節因子
|
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808903A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808914A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TWI763668B
(zh)
|
2016-05-05 |
2022-05-11 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
KR20190015748A
(ko)
|
2016-06-08 |
2019-02-14 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Atf4 경로 억제제로서의 화학적 화합물
|
|
KR20190015492A
(ko)
|
2016-06-08 |
2019-02-13 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
화학적 화합물
|
|
WO2018225093A1
(en)
|
2017-06-07 |
2018-12-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds as atf4 pathway inhibitors
|
|
CA3068753A1
(en)
|
2017-07-03 |
2019-01-10 |
Glaxosmithkline Intellectual Property Development Limited |
N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1]pentan-1-yl)-2-cyclobutane-1-carboxamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
|
|
CA3068395A1
(en)
|
2017-07-03 |
2019-01-10 |
Glaxosmithkline Intellectual Property Development Limited |
2-(4-chlorophenoxy)-n-((1-(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
|
|
CR20200054A
(es)
|
2017-08-09 |
2020-03-21 |
Denali Therapeutics Inc |
Compuestos, composiciones y métodos
|
|
HUE062446T2
(hu)
*
|
2017-09-01 |
2023-11-28 |
Denali Therapeutics Inc |
Vegyületek, készítmények és eljárások
|
|
JP2021501785A
(ja)
|
2017-11-02 |
2021-01-21 |
カリコ ライフ サイエンシーズ エルエルシー |
統合的ストレス経路の調節剤
|
|
UY37957A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
AU2018358157B2
(en)
|
2017-11-02 |
2023-03-09 |
Abbvie Inc. |
Modulators of the integrated stress pathway
|
|
CA3080948A1
(en)
|
2017-11-02 |
2019-05-09 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
UY37956A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
SG11202004009TA
(en)
*
|
2017-11-02 |
2020-05-28 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
WO2019090078A1
(en)
|
2017-11-02 |
2019-05-09 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
UY37958A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
EP3704089B1
(en)
|
2017-11-02 |
2023-07-19 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
AU2018383675A1
(en)
|
2017-12-13 |
2020-07-09 |
Altos Labs, Inc. |
Inhibitors of integrated stress response pathway
|
|
EP3768660A1
(en)
|
2018-03-23 |
2021-01-27 |
Denali Therapeutics Inc. |
Modulators of eukaryotic initiation factor 2
|
|
WO2019193541A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
|
|
WO2019193540A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Heteroaryl derivatives of formula (i) as atf4 inhibitors
|
|
MX2020013269A
(es)
|
2018-06-05 |
2021-02-18 |
Praxis Biotech LLC |
Inhibidores de la vía de respuesta al estrés integrada.
|
|
EP3820843A1
(en)
|
2018-07-09 |
2021-05-19 |
GlaxoSmithKline Intellectual Property Development Limited |
Chemical compounds
|
|
WO2020031107A1
(en)
|
2018-08-08 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
TWI771621B
(zh)
|
2018-10-11 |
2022-07-21 |
美商嘉來克生命科學有限責任公司 |
整合應激路徑之前藥調節劑
|
|
MA54959A
(fr)
|
2019-02-13 |
2021-12-22 |
Denali Therapeutics Inc |
Composés, compositions et procédés
|
|
EP3923935A4
(en)
|
2019-02-13 |
2022-10-26 |
Denali Therapeutics Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
CN113840597A
(zh)
|
2019-02-25 |
2021-12-24 |
普拉西斯生物技术有限责任公司 |
整合应激反应通路抑制剂
|
|
WO2020181247A1
(en)
|
2019-03-06 |
2020-09-10 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
CA3137212A1
(en)
|
2019-04-23 |
2020-10-29 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|
|
IL287379B2
(en)
|
2019-04-23 |
2025-11-01 |
Evotec Int Gmbh |
Modulators of the integrated stress response pathway
|
|
PE20220572A1
(es)
|
2019-04-30 |
2022-04-20 |
Calico Life Sciences Llc |
Moduladores de la via integrada del estres
|
|
EP3962899A1
(en)
|
2019-04-30 |
2022-03-09 |
Calico Life Sciences LLC |
Substituted cyclolakyls as modulators of the integrated stress pathway
|
|
KR20220024486A
(ko)
|
2019-06-12 |
2022-03-03 |
프락시스 바이오테크 엘엘씨 |
통합 스트레스 반응 경로의 억제제
|
|
CN114466654A
(zh)
|
2019-06-12 |
2022-05-10 |
普拉西斯生物技术有限责任公司 |
整合应激反应通路调节剂
|
|
EP4096665A1
(en)
|
2020-01-28 |
2022-12-07 |
Evotec International GmbH |
Modulators of the integrated stress response pathway
|
|
KR20230110509A
(ko)
|
2020-10-22 |
2023-07-24 |
에보텍 인터내셔널 게엠베하 |
통합 스트레스 반응 경로의 조절제
|
|
MX2023004626A
(es)
|
2020-10-22 |
2023-05-23 |
Evotec Int Gmbh |
Moduladores de la via de respuesta integrada al estres.
|
|
AU2021363616B2
(en)
|
2020-10-22 |
2026-03-26 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|